BA

The Boeing Company

57
Fundamentals73/ 100
Valuation50/ 100
Upside potential57/ 100
Risk potential20/ 100

BA has the edge over TRNS overall, supported by stronger valuation and stronger fundamentals.

TRNS

Transcat, Inc.

46
Fundamentals51/ 100
Valuation6/ 100
Upside potential55/ 100
Risk potential26/ 100

TRNS's outlook is improving despite an expensive valuation.

BA Fundamentals

MetricStatus
Stable
Healthy
Stable
Under pressure

BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.

TRNS Fundamentals

MetricStatus
Healthy
Stable
Stable
Stable

TRNS's revenue is currently healthy, and its profitability, cash flow and balance sheet are stable.

BA PE Valuation

CHEAPFAIREXPENSIVE25x51x76x102x
CHEAPFAIREXPENSIVE25x51x76x102x
LevelPEPriceVs current
Current18x$172—
Cheap51x$496+189%
Fair82x$790+360%
Expensive91x$876+411%

Historical ranges are pointers, not guarantees.

BA has the edge over TRNS in the historical PE scenario, which offers more potential upside but is not a forecast.

TRNS PE Valuation

CHEAPFAIREXPENSIVE68x135x203x271x
CHEAPFAIREXPENSIVE68x135x203x271x
LevelPEPriceVs current
Cheap38x$17.80-83%
Forward47x$106—
Fair54x$25.31-76%
Expensive83x$39.15-63%
Current226x$106—

Historical ranges are pointers, not guarantees.

TRNS's PE is in its expensive range at 226x. If earnings grow as analysts expect, today's price would be 47x next year's earnings, in its cheap range.

BA Forward outlook

MetricOutlook
--
Returning to profit
Growth
Improving
Limited
Low

Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.

TRNS Forward outlook

MetricOutlook
Strongly improving
Strong growth
Growth
Improving
Limited
Low

Analysts expect earnings and revenue growth for TRNS, with profitability improving. However, they disagree widely on these estimates.

BA Risk to reward

ScenarioChangePrice
Upside+26%$216.09
Downside-20%$137.47

Calculated from the latest close: $171.55 on Nov 12.

BA has a better modeled risk to reward balance than TRNS, with more potential upside relative to its potential downside.

TRNS Risk to reward

ScenarioChangePrice
Upside+32%$140.02
Downside-26%$79.13

Calculated from the latest close: $106.33 on Nov 12.

TRNS trails BA on modeled risk to reward, with less potential upside relative to its potential downside.

BA Earnings Per Share

Q4 2023: $-3.67Q1 2024: $-3.54Q2 2024: $-5.62Q3 2024: $-12.89Q4 2024: $-18.36Q1 2025: $-17.96Q2 2025: $-16.55Q3 2025: $-13.72Q4 2025: $2.48Q1 2026: $2.53Q2 2026: $2.78Q3 2026: $9.66
Q4 2023: $-3.67Q1 2024: $-3.54Q2 2024: $-5.62Q3 2024: $-12.89Q4 2024: $-18.36Q1 2025: $-17.96Q2 2025: $-16.55Q3 2025: $-13.72Q4 2025: $2.48Q1 2026: $2.53Q2 2026: $2.78Q3 2026: $9.66
QuarterTTM EPSYoY
Q3 2026$9.66+$23.38
Q2 2026$2.78+$19.33
Q1 2026$2.53+$20.49
Q4 2025$2.48+$20.84
Q3 2025-$13.72-$0.83
Q2 2025-$16.55-$10.93
Q1 2025-$17.96-$14.42
Q4 2024-$18.36-$14.69

BA has the edge over TRNS on earnings, with more consistent year-over-year improvement.

TRNS Earnings Per Share

Q4 2023: $1.30Q1 2024: $1.63Q2 2024: $1.73Q3 2024: $2.02Q4 2024: $1.89Q1 2025: $1.57Q2 2025: $1.44Q3 2025: $1.23Q4 2025: $0.86Q1 2026: $0.57Q2 2026: $0.36Q3 2026: $0.47Forward: $2.27
Q4 2023: $1.30Q1 2024: $1.63Q2 2024: $1.73Q3 2024: $2.02Q4 2024: $1.89Q1 2025: $1.57Q2 2025: $1.44Q3 2025: $1.23Q4 2025: $0.86Q1 2026: $0.57Q2 2026: $0.36Q3 2026: $0.47Forward: $2.27
QuarterTTM EPSYoY
Forward$2.27+383%
Q3 2026$0.47-62%
Q2 2026$0.36-75%
Q1 2026$0.57-64%
Q4 2025$0.86-54%
Q3 2025$1.23-39%
Q2 2025$1.44-17%
Q1 2025$1.57-3.7%
Q4 2024$1.89+45%

TRNS's earnings per share have fallen from their peak: $0.47 over the past year, against $2.02 in late 2024.

BA Quarterly Revenue

Q4 2023: $22BQ1 2024: $16.6BQ2 2024: $16.9BQ3 2024: $17.8BQ4 2024: $15.2BQ1 2025: $19.5BQ2 2025: $22.7BQ3 2025: $23.3BQ4 2025: $23.9BQ1 2026: $22.2BQ2 2026: $24.6BQ3 2026: $24.2B
Q4 2023: $22BQ1 2024: $16.6BQ2 2024: $16.9BQ3 2024: $17.8BQ4 2024: $15.2BQ1 2025: $19.5BQ2 2025: $22.7BQ3 2025: $23.3BQ4 2025: $23.9BQ1 2026: $22.2BQ2 2026: $24.6BQ3 2026: $24.2B
QuarterRevenueYoY
Q3 2026$24.2B+3.9%
Q2 2026$24.6B+8%
Q1 2026$22.2B+14%
Q4 2025$23.9B+57%
Q3 2025$23.3B+30%
Q2 2025$22.7B+35%
Q1 2025$19.5B+18%
Q4 2024$15.2B-31%

BA's revenue has grown year over year for seven quarters in a row: $24.2B last quarter, up 3.9% from the same quarter a year ago.

TRNS Quarterly Revenue

Q4 2023: $65MQ1 2024: $71MQ2 2024: $67MQ3 2024: $68MQ4 2024: $67MQ1 2025: $77MQ2 2025: $76MQ3 2025: $82MQ4 2025: $84MQ1 2026: $89MQ2 2026: $93MQ3 2026: $97M
Q4 2023: $65MQ1 2024: $71MQ2 2024: $67MQ3 2024: $68MQ4 2024: $67MQ1 2025: $77MQ2 2025: $76MQ3 2025: $82MQ4 2025: $84MQ1 2026: $89MQ2 2026: $93MQ3 2026: $97M
QuarterRevenueYoY
Q3 2026$97.1M+18%
Q2 2026$92.9M+22%
Q1 2026$89.3M+16%
Q4 2025$83.9M+26%
Q3 2025$82.3M+21%
Q2 2025$76.4M+15%
Q1 2025$77.1M+8.8%
Q4 2024$66.8M+2.4%

TRNS has the edge over BA on sales, with more consistent year-over-year improvement.

BA Free Cash Flow

Q4 2023: $3BQ1 2024: −$3.9BQ2 2024: −$4.3BQ3 2024: −$2BQ4 2024: −$4.1BQ1 2025: −$2.3BQ2 2025: −$200MQ3 2025: $238MQ4 2025: $375MQ1 2026: −$1.5BQ2 2026: $631MQ3 2026: $464M
Q4 2023: $3BQ1 2024: −$3.9BQ2 2024: −$4.3BQ3 2024: −$2BQ4 2024: −$4.1BQ1 2025: −$2.3BQ2 2025: −$200MQ3 2025: $238MQ4 2025: $375MQ1 2026: −$1.5BQ2 2026: $631MQ3 2026: $464M
QuarterFree cash flowYoY
Q3 2026$464M+95%
Q2 2026$631M+$831M
Q1 2026-$1.5B+$836M
Q4 2025$375M+$4.5B
Q3 2025$238M+$2.2B
Q2 2025-$200M+$4.1B
Q1 2025-$2.3B+$1.6B
Q4 2024-$4.1B-239%

BA has the edge over TRNS on cash flow, with more consistent year-over-year improvement.

TRNS Free Cash Flow

Q4 2023: $7MQ1 2024: $2MQ2 2024: $5MQ3 2024: $3MQ4 2024: $10MQ1 2025: $8MQ2 2025: −$975,000Q3 2025: $8MQ4 2025: $9MQ1 2026: $3MQ2 2026: $5MQ3 2026: $6M
Q4 2023: $7MQ1 2024: $2MQ2 2024: $5MQ3 2024: $3MQ4 2024: $10MQ1 2025: $8MQ2 2025: −$975,000Q3 2025: $8MQ4 2025: $9MQ1 2026: $3MQ2 2026: $5MQ3 2026: $6M
QuarterFree cash flowYoY
Q3 2026$6.1M-28%
Q2 2026$4.8M+$5.8M
Q1 2026$2.6M-67%
Q4 2025$9.5M-2.7%
Q3 2025$8.4M+194%
Q2 2025-$975K-119%
Q1 2025$7.9M+413%
Q4 2024$9.7M+34%

TRNS generated $23M in free cash flow over the past year, down 8.6% from the year before.

BA Total Shares

Q4 2023: 606MQ1 2024: 613MQ2 2024: 616MQ3 2024: 619MQ4 2024: 647MQ1 2025: 753MQ2 2025: 757MQ3 2025: 760MQ4 2025: 762MQ1 2026: 788MQ2 2026: 791MQ3 2026: 793M
Q4 2023: 606MQ1 2024: 613MQ2 2024: 616MQ3 2024: 619MQ4 2024: 647MQ1 2025: 753MQ2 2025: 757MQ3 2025: 760MQ4 2025: 762MQ1 2026: 788MQ2 2026: 791MQ3 2026: 793M
PeriodChange %Net change
Quarterly+0.3%+2.1M shares
1 year+4.3%+32.8M shares
3 years+31%+186M shares
5 years+35%+204M shares
Available history+40%+227M shares

BA has 793M diluted shares, up 4.3% from a year ago.

TRNS Total Shares

Q4 2023: 9MQ1 2024: 8MQ2 2024: 9MQ3 2024: 9MQ4 2024: 9MQ1 2025: 9MQ2 2025: 9MQ3 2025: 9MQ4 2025: 9MQ1 2026: 9MQ2 2026: 9MQ3 2026: 10M
Q4 2023: 9MQ1 2024: 8MQ2 2024: 9MQ3 2024: 9MQ4 2024: 9MQ1 2025: 9MQ2 2025: 9MQ3 2025: 9MQ4 2025: 9MQ1 2026: 9MQ2 2026: 9MQ3 2026: 10M
PeriodChange %Net change
Quarterly+0.8%+74K shares
1 year+1.6%+148K shares
3 years+20%+1.6M shares
5 years+26%+2M shares
Available history+26%+2M shares

TRNS has the edge over BA on shareholder dilution, with a more favorable share count trend.

BA Net Leverage

Q4 2023: 36.4xQ1 2024: 36.1xQ2 2024: 361.8xQ4 2025: 6.9xQ1 2026: 6.0xQ2 2026: 5.7xQ3 2026: 3.0x
Q4 2023: 36.4xQ1 2024: 36.1xQ2 2024: 361.8xQ4 2025: 6.9xQ1 2026: 6.0xQ2 2026: 5.7xQ3 2026: 3.0x
QuarterNet LeverageStatus
Q3 20263.0xElevated
Q2 20265.7xHigh
Q1 20266.0xHigh
Q4 20256.9xHigh
Q2 2024361.8xHigh
Q1 202436.1xHigh
Q4 202336.4xHigh
Q3 202396.1xHigh

BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.

TRNS Net Leverage

Q4 2023: -1.1xQ1 2024: -0.5xQ2 2024: -0.5xQ3 2024: -0.5xQ4 2024: 1.0xQ1 2025: 0.9xQ2 2025: 0.9xQ3 2025: 2.7xQ4 2025: 2.4xQ1 2026: 2.4xQ2 2026: 2.7xQ3 2026: 2.7x
Q4 2023: -1.1xQ1 2024: -0.5xQ2 2024: -0.5xQ3 2024: -0.5xQ4 2024: 1.0xQ1 2025: 0.9xQ2 2025: 0.9xQ3 2025: 2.7xQ4 2025: 2.4xQ1 2026: 2.4xQ2 2026: 2.7xQ3 2026: 2.7x
QuarterNet LeverageStatus
Q3 20262.7xModerate
Q2 20262.7xModerate
Q1 20262.4xModerate
Q4 20252.4xModerate
Q3 20252.7xModerate
Q2 20250.9xVery low
Q1 20250.9xVery low
Q4 20241.0xHealthy

TRNS has the edge over BA on leverage, with a lower net debt burden relative to earnings.

BA Weekly Momentum

MetricValueStatus
RSI31.1Neutral
Stochastic9.6Oversold

BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).

TRNS Weekly Momentum

MetricValueStatus
RSI68.7Neutral
Stochastic62.5Neutral

TRNS's weekly RSI is 69 (neutral) and its Stochastic is 62 (neutral).

BA PE vs Industrials Sector

MetricBASector medianRelative
PE18x24x26% below
PE %05858 pts below

BA has the edge over TRNS on valuation relative to its sector.

TRNS PE vs Industrials Sector

MetricTRNSSector medianRelative
PE226x24x840% above
PE %975839 pts above

TRNS is trading at 226x earnings, a 840% premium to the Industrials sector's median of 24x.

BA Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$184.67.1% below
20 week MA$203.816% below
50 week MA$215.520% below
100 week MA$205.917% below
200 week MA$200.614% below

BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.

TRNS Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$90.118% above
20 week MA$88.920% above
50 week MA$79.434% above
100 week MA$79.933% above
200 week MA$91.516% above

TRNS has the edge over BA on trend strength, trading above more of its moving averages.

BA Yearly ROI

YearStart priceEnd priceROI
2020$330.1$217.2-34%
2021$217.2$204.2-6%
2022$204.2$189.1-7.4%
2023$189.1$260.7+38%
2024$260.7$180.7-31%
2025$180.7$216.4+20%
2026 YTD$216.4$171.6-21%

BA has finished lower in four of the last six years. It's down 21% so far in 2026.

TRNS Yearly ROI

YearStart priceEnd priceROI
2020$31.8$33.0+3.8%
2021$33.0$92.9+181%
2022$92.9$70.0-25%
2023$70.0$109.3+56%
2024$109.3$106.0-3%
2025$106.0$58.9-44%
2026 YTD$58.9$106.3+81%

TRNS has the edge over BA on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key